Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KPL (Kirkegaard & Perry Laboratories) is a specialized biotechnology company that develops and manufactures high-quality antibodies and reagents for the life sciences and diagnostic industries. Founded in 1979 and headquartered in Gaithersburg, Maryland, the company became a leader in the production of affinity-purified secondary antibodies and chromogenic substrates for ELISA and immunohistochemistry. KPL's product portfolio supports a wide range of applications, including protein detection, food safety testing, and infectious disease research. In 2013, KPL was acquired by SeraCare Life Sciences, and it now operates as a key brand within the LGC Clinical Diagnostics division. The company's legacy continues through its widely used BacTrace and TMB substrate product lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KPL.